SMi Reports: The countdown begins to the highly anticipated Drug Discovery Chemistry conference in London. The drug discovery field is undergoing dramatic change with a new opportunity for the development of novel medicines and technologies […]
Pfizer has partnered with non-profit healthcare system Ochsner Health System to develop digital models that aim to improve clinical trials. The multi-year strategic alliance involves Ochsner’s innovation lab innovationOchsner (iO) and Ochsner Research. Pfizer and […]
Amgen, Cytokinetics, and Servier announced that METEORIC-HF (Multicenter Exercise Tolerance Evaluation of Omecamtiv Mecarbil Related to Increased Contractility in Heart Failure), the second Phase 3 clinical trial of omecamtiv mecarbil, a novel cardiac myosin activator, […]
Sosei Group announced that the first healthy subject has been dosed with a small molecule HTL0030310 in a Phase I clinical study, marking the start of a new in-house clinical program targeting endocrine disorders, including […]
Science and technology firm Danaher has agreed to acquire the biopharma business of GE Life Sciences (GE Biopharma) for a cash purchase price of about $21.4bn. Danaher seeks to help its customers solve complex challenges […]